Search

Author/Creator Batra, Jaspreet S.

1. Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer. Issue 15 (23rd April 2019)

Authors:
Tagawa, Scott T.; Vallabhajosula, Shankar; Christos, Paul J.; Jhanwar, Yuliya S.; Batra, Jaspreet S.; Lam, Linda; Osborne, Joseph; Beltran, Himisha; Molina, Ana M.; Goldsmith, Stanley J.; Bander, Neil H.; Nanus, David M.
Journal:
Cancer
Issue:
Volume 125:Issue 15(2019)
Page Start:
2561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (177Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer. (30th January 2020)

Authors:
Niaz, Muhammad Junaid; Batra, Jaspreet S.; Walsh, Ryan D.; Ramirez‐Fort, Marigdalia K.; Vallabhajosula, Shankar; Jhanwar, Yuliya S.; Molina, Ana M.; Nanus, David M.; Osborne, Joseph R.; Bander, Neil H.; Tagawa, Scott T.
Journal:
Oncologist
Issue:
Volume 25:Number 6(2020)
Page Start:
477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search